Honasa Consumer Acquires 58% Stake in Fluence Pharma, Enters Nutraceuticals
Mamaearth parent Honasa Consumer takes 58% majority stake in Fluence Pharma, extending its 'inside-out' beauty strategy into nutraceuticals via patented Cyclical Nutrition Therapy and dermatologist-led distribution channels.
Honasa Consumer acquires 58% majority stake in Fluence Pharma, entering the nutraceuticals space with patented Cyclical Nutrition Therapy and dermatologist-led distribution, extending its 'inside-out' beauty strategy. Separately, Imagicaa Water Park in Khopoli resumes operations June 26 after rain disruption.
Why this matters
Honasa moves beyond topical beauty into ingestibles, launching Honasa Health to compete in a ₹16,000-cr category. Deal lands as the stock trades under pressure amid broader market weakness.
Retail-company signals steady at 3,588 over the last 90 days, reflecting consistent corporate activity.